Primary Health Care — Screening for Therapy and Empowering Parents: A Pilot Study
Citation(s)
Berry AD, Garzon DL, Mack P, Kanwischer KZ, Beck DG Implementing an early childhood developmental screening and surveillance program in primary care settings: lessons learned from a project in Illinois. J Pediatr Health Care. 2014 Nov-Dec;28(6):516-25. d
Dobrez D, Sasso AL, Holl J, Shalowitz M, Leon S, Budetti P Estimating the cost of developmental and behavioral screening of preschool children in general pediatric practice. Pediatrics. 2001 Oct;108(4):913-22. doi: 10.1542/peds.108.4.913.
Earls MF, Hay SS Setting the stage for success: implementation of developmental and behavioral screening and surveillance in primary care practice--the North Carolina Assuring Better Child Health and Development (ABCD) Project. Pediatrics. 2006 Jul;118(1
Frankenburg WK Developmental surveillance and screening of infants and young children. Pediatrics. 2002 Jan;109(1):144-5. doi: 10.1542/peds.109.1.144. No abstract available.
Rosenberg SA, Zhang D, Robinson CC Prevalence of developmental delays and participation in early intervention services for young children. Pediatrics. 2008 Jun;121(6):e1503-9. doi: 10.1542/peds.2007-1680. Epub 2008 May 26.
Schonwald A, Huntington N, Chan E, Risko W, Bridgemohan C Routine developmental screening implemented in urban primary care settings: more evidence of feasibility and effectiveness. Pediatrics. 2009 Feb;123(2):660-8. doi: 10.1542/peds.2007-2798.
Early STEPs: Screening for Therapy and Empowering Parents: A Pilot Study
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
